High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
about
Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.EphA8 is a prognostic marker for epithelial ovarian cancer.Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancerKIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer.LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.CACNA1B (Cav2.2) Overexpression and Its Association with Clinicopathologic Characteristics and Unfavorable Prognosis in Non-Small Cell Lung Cancer.The small heat shock protein αA-crystallin negatively regulates pancreatic tumorigenesisHigh TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.The prognostic implications of growth-related gene product β in laryngeal squamous cell carcinoma.Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.Downregulation of Epstein-Barr virus-induced gene 3 is associated with poor prognosis of hepatocellular carcinoma after curative resection.Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells
P2860
Q36545609-DF77E556-90B3-4333-917F-D047EB90AFA5Q37004325-34CB38DE-35DA-49A0-91EF-DEA0D6AD4D06Q37190444-87BA299A-E50E-4248-8373-A9133E8B7683Q37249091-BF283BBD-4158-4463-9DD3-50998FA5EB97Q37330144-9714E278-A48B-480E-8511-6F28841853C5Q37564340-395B5376-B4E3-4DA5-A77F-76A8024F0801Q37588691-A48EA9AB-E926-4ECA-8B79-25D2F171153AQ37662315-8811C01E-5E46-4D78-9F53-6EE7686F04B2Q37706501-870B21BA-8EE2-416B-9A50-E24B1FF1D7BEQ37723027-EB331D24-5106-4CE7-8C8D-311EDAFC3578Q38800075-F6D9DC42-6609-4E7D-9D57-9A3104EEDBFFQ41619876-E6BE1066-204E-4EE5-BE2D-B145D83D44C6Q47100343-8015A419-92BE-4419-82BD-DD1FC50D4D52Q48276795-FEAFDF48-3764-4257-983D-61BC3D313D81Q49658859-6545DF72-D9DA-48FA-B192-13D4AF1EE5CFQ54217573-A3CDF298-CED2-4064-858C-01A16C678AF8Q59132143-EAFF52F9-2281-4D83-9C3B-BC9D8736E539
P2860
High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
High ROR2 expression in tumor ...... creatic ductal adenocarcinoma.
@ast
High ROR2 expression in tumor ...... creatic ductal adenocarcinoma.
@en
type
label
High ROR2 expression in tumor ...... creatic ductal adenocarcinoma.
@ast
High ROR2 expression in tumor ...... creatic ductal adenocarcinoma.
@en
prefLabel
High ROR2 expression in tumor ...... creatic ductal adenocarcinoma.
@ast
High ROR2 expression in tumor ...... creatic ductal adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
High ROR2 expression in tumor ...... ncreatic ductal adenocarcinoma
@en
P2093
Huijun Zhu
Xiangjun Fan
Xudong Wang
Zhiwei Wang
P2860
P2888
P356
10.1038/SREP12991
P407
P577
2015-08-11T00:00:00Z